Latest period
$257.30M
YoY change
-24.2%
5Y CAGR
+10.4%
Peak year (2024)
$377.00M
Cumulative CapEx
$4.21B
CapEx history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: $285.90M
CapEx growth chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: -24.2%
CapEx history table for West Pharmaceutical Services (WST) from 1989 to 2025
| 2025 | $285.90M | -24.2% | −$91.10M | ||
| 2024 | $377.00M | +4.1% | +$15.00M | ||
| 2023 | $362.00M | +27.2% | +$77.40M | ||
| 2022 | $284.60M | +12.3% | +$31.20M | ||
| 2021 | $253.40M | +45.3% | +$79.00M | ||
| 2020 | $174.40M | +38.0% | +$48.00M | ||
| 2019 | $126.40M | +20.7% | +$21.70M | ||
| 2018 | $104.70M | -20.0% | −$26.10M | ||
| 2017 | $130.80M | -23.1% | −$39.40M | ||
| 2016 | $170.20M | +29.3% | +$38.60M | ||
| 2015 | $131.60M | +17.4% | +$19.50M | ||
| 2014 | $112.10M | -28.0% | −$43.70M | ||
| 2013 | $155.80M | +18.0% | +$23.80M | ||
| 2012 | $132.00M | +36.4% | +$35.20M | ||
| 2011 | $96.80M | +31.2% | +$23.00M | ||
| 2010 | $73.80M | -31.5% | −$34.00M | ||
| 2009 | $107.80M | -22.5% | −$31.30M | ||
| 2008 | $139.10M | +7.5% | +$9.70M | ||
| 2007 | $129.40M | +43.3% | +$39.10M | ||
| 2006 | $90.30M | +66.9% | +$36.20M | ||
| 2005 | $54.10M | -5.7% | −$3.30M | ||
| 2004 | $57.40M | -5.6% | −$3.40M | ||
| 2003 | $60.80M | +61.3% | +$23.10M | ||
| 2002 | $37.70M | -14.5% | −$6.40M | ||
| 2001 | $44.10M | -23.0% | −$13.20M | ||
| 2000 | $57.30M | -9.6% | −$6.10M | ||
| 1999 | $63.40M | -17.3% | −$13.30M | ||
| 1998 | $76.70M | +123.0% | +$42.30M | ||
| 1997 | $34.40M | +8.5% | +$2.70M | ||
| 1996 | $31.70M | +1.3% | +$400.00K | ||
| 1995 | $31.30M | +15.5% | +$4.20M | ||
| 1994 | $27.10M | -19.1% | −$6.40M | ||
| 1993 | $33.50M | +49.6% | +$11.10M | ||
| 1992 | $22.40M | -12.2% | −$3.10M | ||
| 1991 | $25.50M | -23.2% | −$7.70M | ||
| 1990 | $33.20M | -3.2% | −$1.10M | ||
| 1989 | $34.30M | — | — |
- 2025$285.90M-24.2%
- 2024$377.00M+4.1%
- 2023$362.00M+27.2%
- 2022$284.60M+12.3%
- 2021$253.40M+45.3%
- 2020$174.40M+38.0%
- 2019$126.40M+20.7%
- 2018$104.70M-20.0%
- 2017$130.80M-23.1%
- 2016$170.20M+29.3%
- 2015$131.60M+17.4%
- 2014$112.10M-28.0%
- 2013$155.80M+18.0%
- 2012$132.00M+36.4%
- 2011$96.80M+31.2%
- 2010$73.80M-31.5%
- 2009$107.80M-22.5%
- 2008$139.10M+7.5%
- 2007$129.40M+43.3%
- 2006$90.30M+66.9%
- 2005$54.10M-5.7%
- 2004$57.40M-5.6%
- 2003$60.80M+61.3%
- 2002$37.70M-14.5%
- 2001$44.10M-23.0%
- 2000$57.30M-9.6%
- 1999$63.40M-17.3%
- 1998$76.70M+123.0%
- 1997$34.40M+8.5%
- 1996$31.70M+1.3%
- 1995$31.30M+15.5%
- 1994$27.10M-19.1%
- 1993$33.50M+49.6%
- 1992$22.40M-12.2%
- 1991$25.50M-23.2%
- 1990$33.20M-3.2%
- 1989$34.30M—
CapEx values are taken from West Pharmaceutical Services's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current CapEx (TTM) is $257.30M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, West Pharmaceutical Services (WST) reported CapEx of $285.90M – declined 24.2% year-over-year.
West Pharmaceutical Services CapEx has grown on net over the period, with a +10.4% compound annual growth rate over 2020–2025 (5 years).
Between 2024 and 2025, West Pharmaceutical Services CapEx declined 24.2%, falling from $377.00M to $285.90M.
$377.00M stands as the all-time-high annual CapEx, posted in 2024, against a low of $22.40M during 1992.
West Pharmaceutical Services Capital Expenditures by Year
West Pharmaceutical Services Capital Expenditures 2025: $285.90M
West Pharmaceutical Services CapEx in 2025 was $285.90M, declined 24.2% below 2024.
West Pharmaceutical Services Capital Expenditures 2024: $377.00M
2024's CapEx for West Pharmaceutical Services came in at $377.00M, edged up 4.1% from 2023. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Capital Expenditures 2023: $362.00M
West Pharmaceutical Services posted CapEx of $362.00M in 2023, grew 27.2% from 2022.
West Pharmaceutical Services Capital Expenditures 2022: $284.60M
In 2022, West Pharmaceutical Services reported CapEx of $284.60M, grew 12.3% from 2021.
West Pharmaceutical Services Capital Expenditures 2021: $253.40M
West Pharmaceutical Services CapEx in 2021 was $253.40M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by CapEx
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation